CAPA
Corrective and Preventive Action
CAPA (Corrective and Preventive Action) is 医療機器の製造および運用における品質問題を調査、是正、予防するための体系的なアプローチ。
Complete Guide to CAPA
CAPA (Corrective and Preventive Action) is a fundamental quality management system process used to systematically investigate and eliminate the root causes of quality issues, nonconformances, and potential problems in medical device manufacturing and operations.
Definition and purpose in quality systems:
CAPA is a proactive quality management tool that ensures organizations learn from mistakes, prevent recurrence, and continuously improve their processes. It forms the backbone of a robust Quality Management System (QMS) by addressing both existing problems (corrective action) and potential problems (preventive action).
Corrective vs Preventive Action:
- Corrective Action - Addresses existing nonconformances or problems that have already occurred. The focus is on identifying root causes and implementing solutions to prevent recurrence.
- Preventive Action - Addresses potential problems before they occur. This involves analyzing trends, data, and risk assessments to eliminate potential causes of future nonconformances.
FDA 21 CFR 820.100 requirements:
The FDA's Quality System Regulation (QSR) mandates CAPA procedures that include:
- Analyzing processes, work operations, complaints, quality data, and service records
- Investigating causes of nonconformances
- Identifying actions needed to correct and prevent recurrence
- Verifying or validating the corrective and preventive actions
- Ensuring that information related to quality problems or nonconformances is disseminated to those directly responsible
- Submitting relevant information on identified quality problems and corrective actions to management review
- Documenting all CAPA activities
ISO 13485 CAPA requirements:
ISO 13485:2016 separates corrective action (Clause 8.5.2) and preventive action (Clause 8.5.3), requiring organizations to:
- Review nonconformities including customer complaints
- Determine causes of nonconformities
- Evaluate the need for actions
- Implement actions needed
- Review the effectiveness of corrective actions taken
- Update risk management documentation
CAPA process steps:
1. Identify - Detection of actual or potential problems through various sources
2. Investigate - Gather data, facts, and evidence related to the problem
3. Root Cause Analysis - Use tools like 5 Whys, Fishbone diagrams, or Failure Mode Effects Analysis (FMEA) to identify true underlying causes
4. Implement - Develop and execute action plans to address root causes
5. Verify Effectiveness - Confirm that implemented actions resolved the problem and prevented recurrence
6. Document - Maintain comprehensive records throughout the process
Common triggers for CAPA:
- Customer complaints and returns
- Internal audit findings
- Regulatory inspection observations (FDA 483s, warning letters)
- Nonconforming products or processes
- Management review findings
- Supplier quality issues
- Post-market surveillance data (adverse events, field actions)
- Process monitoring trends
- Employee suggestions
Documentation requirements:
Complete CAPA documentation must include:
- Problem description and source
- Investigation findings and data analysis
- Root cause determination methodology and results
- Proposed corrective/preventive actions with justification
- Implementation plan with responsibilities and timelines
- Effectiveness verification methods and results
- Closure approval and date
Metrics and trending:
Effective CAPA systems track key performance indicators:
- Number of CAPAs opened/closed per period
- Average time to close CAPAs
- CAPA effectiveness rate (% that prevent recurrence)
- CAPAs by source (complaints, audits, etc.)
- CAPAs by product line or process area
- Overdue CAPA aging
- Root cause categories for trend analysis
A well-implemented CAPA system demonstrates regulatory compliance, reduces product defects, minimizes customer complaints, and drives continuous improvement in medical device organizations.
Related Terms
More Compliance & Standards
View allFDAの品質システム規制(QSR)で、米国の医療機器製造業者に対する現行の適正製造基準(cGMP)要件を定めたもの。
品質活動と結果が計画された取り決めに準拠しているか、およびこれらの取り決めが効果的に実施されているかを判断するための、品質マネジメントシステムの体系的で独立した検査。
欧州経済領域で販売される医療機器の必須適合マーキング。EUの健康、安全、環境要件への適合を示す。
21 CFR 820.30に基づくFDA要件で、医療機器の設計を管理し、ユーザーニーズと意図する用途を満たすための手順を確立します。
Need Help with Global Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate Global market access.

